Age [years]: median (range) |
13 (10–15) |
13 (10–15) |
12 (10–13) |
12 (10–15) |
12 (11–15) |
0.657 |
2.433 |
4 |
Age [years]: mean (SD) |
12.2 (2.2) |
12.5 (2.0) |
11.5 (1.3) |
12.5 (1.8) |
12.7 (2.1) |
|
|
|
Therapeutic range [μmol/l] |
42–900 |
42–900 |
42–900 |
42–900 |
42–900 |
|
|
|
Median Phe-concentration [μmol/l] |
361 |
565 |
532 |
627 |
629 |
0.831 |
1.577 |
4 |
Median Phe-concentration [μmol/l]: range |
119–810 |
170–1157 |
119–844 |
184–812 |
584–802 |
|
|
|
Median Phe-concentration [μmol/l]: interquartile range(IQR) |
232–713 |
310–716 |
298–655 |
360–757 |
584–802 |
|
|
|
Median Phe-concentrations > therapeutic range [%] |
0 |
20 |
0 |
0 |
17 |
0.393 |
4.178 |
4 |
Median Phe-concentrations > therapeutic range [%]: range |
0–50 |
0–83 |
0–33 |
0–17 |
0–33 |
|
|
|
Median Phe-concentrations > therapeutic range [%]: IQR |
0–25 |
0–38 |
0–17 |
0–4 |
0–33 |
|
|
|
Phe intake [mg]: median (range) |
500 (190–750) |
355 (200–750) |
350 (200–650) |
420 (290–750) |
550 (500–650) |
0.212 |
5.835 |
4 |
Adherence to amino acid mixture: median (range) |
5 (4–5) |
5 (4–5) |
5 (1–5) |
5 (4–5) |
5 (5–5) |
0.405 |
4.018 |
4 |
Burden of dietary regime: median (range) |
3 (2–5) |
3 (1–4) |
3 (1–5) |
3 (1–5) |
4 (2–3) |
0.819 |
1.627 |
4 |